Clinical Trial

Non Invasive Neurostimulation Technology for the Treatment of Type I Complex Regional Pain Syndrome (CRPS I)

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 28, 2025 (before its estimated April 27, 2026 completion). Its status may not reflect the trial's current state.
Summary
Complex Regional Pain Syndrome (CRPS) / Complex Regional Pain Syndrome (CRPS) is a chronic neurological disorder that affects the extremities and is characterized by disabling pain, swelling, vasomotor instability, sudomotor abnormality, and impaired motor function; the duration and clinical magnitude is greater than expected, being divided into three stages of progression over time: Stage I: acute (0-3 months); Stage II: dystrophic (3-9 months); Stage 3: atrophic (9-18 months). The purpose of this study is to investigate the effect on complex pain syndrome using a conventional care protocol plus the application of non-invasive neuromodulation during compared to the effect of the same protocol plus placebo.
Protocol Amendment History 15 amendments
This ClinicalTrials.gov record has been amended 15 times since 2021-09-12; most recent amendment 2025-08-21.
Status change: Not Yet Recruiting → Recruiting 2022-04-30
Trial Details
NCT Number NCT05052736
Lead Sponsor University of Las Palmas de Gran Canaria
Conditions Type I Complex Regional Pain Syndrome
Enrollment 42 participants
Start Date 2022-03-28
Primary Completion 2026-04-27 (estimated)
Study Completion 2026-12-27 (estimated)
Updated on ClinicalTrials.gov 2025-08-28